| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-723 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94219e7f57927f3926c6b9528c97b968
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d948d8b629588d65b5d3042ed00e84e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ec499fe4acf519e075b5790ca33ae51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89d5bd271628b37fdba7a3754d67e06a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb5599e1ea0d17d8478108cab258cd12 |
| publicationDate |
2009-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2077278-A1 |
| titleOfInvention |
Peptide derived from neurotensin receptor 3 and use in the treatment of psychiatric disorders |
| abstract |
The present invention relates to a peptide derived from the neurotensin 3 receptor (NSTR3) and its use in the treatment of psychiatric diseases. The present invention relates in particular to the use of this peptide for the manufacture of a medicament, for example an antidepressant. The peptide of the invention is characterized in that its sequence is the attached SEQ ID No. 1.n n n The present invention finds application in the pharmaceutical industry and in particular in the fields of drug development in the treatment of psychiatric diseases. The present invention finds particular application in the development of a new antidepressant. It finds for example also an application in the treatment of pain and inflammatory processes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10251937-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015110915-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11780882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108473541-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8252748-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009103898-A1 |
| priorityDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |